Social Studies of Science
AbstractPublication of pharmaceutical company-sponsored research in medical journals, and its presentation at conferences and meetings, is mostly governed by ‘publication plans’ that extract the maximum amount of scientific and commercial value out of data and analyses through carefully constructed and placed papers. Clinical research is typically performed by contract research organizations, analyzed by company statisticians, written up by independent medical writers, approved and edited by academic researchers who then serve as authors, and the whole process organized and shepherded through to journal publication by publication planners. This paper reports on a conference of an international association of publication planners. It describes and analyzes their work in an ecological framework that relates it to marketing departments of pharmaceutical companies, medical journals and publishers, academic authors, and potential audiences. The medical research described here forms a new kind of corporate science, designed to look like traditional academic work, but performed largely to market products.
Similar books and articles
Publication ethics and the ghost management of medical publication.Sergio Sismondo & Mathieu Doucet - 2010 - Bioethics 24 (6):273-283.
Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry?Sergio Sismondo - manuscript
Teaching Authorship and Publication Practices in the Biomedical and Life Sciences.Francis L. Macrina - 2011 - Science and Engineering Ethics 17 (2):341-354.
Conflict of interest and medical publication.Marcus M. Reidenberg - 2002 - Science and Engineering Ethics 8 (3):455-457.
Conflicts of interest in drug development: The practices of merck & co., inc.Laurence J. Hirsch - 2002 - Science and Engineering Ethics 8 (3):429-442.
Medical journals' conflicts of interest in the publication of book reviews.Ronald M. Davis, Anne Victoria Neale & Joseph C. Monsur - 2003 - Science and Engineering Ethics 9 (4):471-483.
Conflict of interest as seen from a researcher’s perspective.Arrigo Schieppati, Norberto Perico & Giuseppe Remuzzi - 2002 - Science and Engineering Ethics 8 (3):337-342.
Those Who Have the Gold Make the Evidence: How the Pharmaceutical Industry Biases the Outcomes of Clinical Trials of Medications. [REVIEW]Joel Lexchin - 2012 - Science and Engineering Ethics 18 (2):247-261.
Publication Ethics in Biomedical Journals from Countries in Central and Eastern Europe.Mindaugas Broga, Goran Mijaljica, Marcin Waligora, Aime Keis & Ana Marusic - 2013 - Science and Engineering Ethics (1):1-11.
Publication visibility of sensitive public health data: When scientists Bury their results.David A. Rier - 2004 - Science and Engineering Ethics 10 (4):597-613.
Managing dual use technology: It takes two to tango.Lalit Kant & D. T. Mourya - 2010 - Science and Engineering Ethics 16 (1):77-83.
Ethical and Legal Issues in Publication and Dissemination of Scholarly Knowledge: A Summary of the Published Evidence. [REVIEW]Krishna Regmi - 2011 - Journal of Academic Ethics 9 (1):71-81.
Medicine, Methodology, and Values: Trade-Offs in Clinical Science and Practice.Vincent K. Y. Ho - 2011 - Perspectives in Biology and Medicine 54 (2):243-255.
Problems for biomedical research at the academia-industrial interface.David Weatherall - 2003 - Science and Engineering Ethics 9 (1):43-48.
Added to PP
Historical graph of downloads
Citations of this work
No citations found.
References found in this work
Science in Action: How to Follow Scientists and Engineers Through Society.Bruno Latour - 1987 - Harvard University Press.
Changing Order: Replication and Induction in Scientific Practice.Harry Collins - 1985 - Chicago, IL, USA: University of Chicago Press.
Constructing Quarks: A sociological history of particle physics.Andrew Pickering - 1984 - University of Chicago Press.
Knowledge and Social Imagery.David Bloor - 1979 - British Journal for the Philosophy of Science 30 (2):195-199.